Immunotherapy in advanced anal cancer: is the beginning of a new era?

Anal cancer is a rare disease that accounts for less than 3% of all gastrointestinal tumors [1]. The incidence of its most common histologic variant, squamous cell carcinoma of the anus (SCCA) is 0.5- 2 cases/100.000 per year, although it has been steadily increasing in the latest years [1-5].

Source: Cancer Treatment Reviews - March 8, 2022 Category: Cancer & Oncology Authors: Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, Paola Parente, Tiziana Pia Latiano, Massimo Di Maio, Fortunato Ciardiello, Teresa Troiani, Erika Martinelli, Evaristo Maiello Tags: Anti-tumour Treatment Source Type: research